Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Investigation of Anaphylaxis, Allergic-like Reactions and Oculo-Respiratory Syndrome (ORS) Following Administration of an Adjuvanted Vaccine Against H1N1 Pandemic Influenza

NCT01247415 is registered in ClinicalTrials.gov with PHAC/CIHR Influenza Research Network as lead sponsor.

NCT NCT01247415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01247415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Investigation of Anaphylaxis, Allergic-like Reactions and Oculo-Respiratory Syndrome (ORS) Following Administration of an Adjuvanted Vaccine Against H1N1 Pandemic Influenza
Lead sponsor
PHAC/CIHR Influenza Research Network
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2011
Completion date
November 30, 2012
Enrollment
138 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

allergic-like reactions, allergy, anaphylaxis, oculorespiratory syndrome